martine j. piccart-gebhart, et al.
Published 10 years ago • 323 plays • Length 10:04Download video MP4
Download video MP3
Similar videos
-
35:28
hormone receptor positive disease: new developments - martine j. piccart-gebhart, m.d., ph.d.
-
5:01
martine j piccart-gebhart, jules bordet institute, université libre de bruxelles
-
3:23
martine piccart-gebhart
-
17:57
martine piccart-gebhart: survival follow-up analysis of the neoaltto study (big 1-06)
-
19:23
martine piccart: patients with her2 positive breast cancer
-
21:19
estrogen receptors & her2/neu receptors in breast cancer (a tutorial from oster oncology)
-
24:38
stage 4 matastatic her 2 positive breast cancer third line enhertu and fourth line of treatment
-
5:05
anti-her2 mechanisms of approved her2 inhibitors
-
6:23
martine piccart, md, phd: can patients and advocates help with tissue and biospecimen collection?
-
11:07
adjuvant therapy for early stage er-positive, her2-negative invasive breast cancer
-
3:56
using mammaprint to select patients who may not need adjuvant chemotherapy – the results of mindact
-
5:59
dr. martine piccart on her2-targeted therapies in breast cancer
-
3:55
onc-chat: dr. martine piccart, 'absolutely no advantage' to 2 years of trastuzumab
-
2:40
dr martine piccart on the aurora project
-
8:27
martine piccart, md, phd: no benefit in extending herceptin in her2 breast cancer
-
14:29
martine piccart, md, phd: her goals as the current president of esmo
-
5:07
martine piccart, md, phd: impakt meeting 2012
-
2:49
dr. piccart on the changing view of anti-her2 therapies
-
1:04:29
debate anthracyclines…to give or not to give
-
3:15
prof. martine piccart
-
2:39
biomarker-driven therapies for triple-negative breast cancer